Loading clinical trials...
Loading clinical trials...
Phase II Single-arm Study of First Line Treatment With Gemcitabine and Pazopanib in Patients With Inoperable Locally Advanced or Metastatic Biliary Tree Cancer (Cholangiocarcinoma or Gallbladder Carcinoma)
Conditions
Interventions
Gemcitabine-Pazopanib
Locations
17
Greece
2nd Dept of Internal Medicine, Agios Savvas Cancer Hospital
Athens, Greece
Dept of Medical Oncology, 251 General Air Force Hospital
Athens, Greece
2nd Dept of Internal Medicine, General Hospital of Athens "Hippokratio"
Athens, Greece
Oncology Dept, 2nd Surgyc Clinic, Aretaieio Hospital
Athens, Greece
Oncology Section, Dept of Clinical Therapeutics, General Hospital of Athens "Alexandra"
Athens, Greece
Division of Oncology, 2nd Dept of Internal Medicine, Propaedeutic, University Hospital "Attikon"
Athens, Greece
Start Date
June 28, 2013
Primary Completion Date
September 15, 2018
Completion Date
September 28, 2018
Last Updated
November 7, 2018
NCT07282912
NCT07146646
NCT04753996
NCT05430698
NCT06313203
NCT04421820
Lead Sponsor
Hellenic Cooperative Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions